Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GNG7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PHIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SLC15A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLHL41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELMOD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM95A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZNF200 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLHL31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJC8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IKZF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100130331 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C16orf74 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HINT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLRA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AP5M1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on